How it works
A GLP-1 receptor agonist studied for glucose-dependent signaling, gastric emptying, and central satiety pathways.
Who it is for
Studied for obesity, overweight, type 2 diabetes, and cardiometabolic risk.
Key benefits
Key benefits include glucose regulation, energy intake, satiety, and cardiometabolic markers.
